Mylan Launches Dymista® in Malaysia
PETALING JAYA, 24 August 2018 – Mylan, one of the world's leading global pharmaceutical companies, today, announced the launch of Dymista ®, a new class of treatment for Allergic Rhinitis (AR) in Malaysia at a conference.This new advanced breakthrough product contains two main active ingredients – Azelastine Hydrochloride and Fluticasone propionate that provide significant relief …
Get Price